Skip to content

Comparison of blood transfusion in patient received tranexamic acid in femoral shaft fracture who operated with plate and screw fixation, randomized control trial.

Comparison of blood transfusion in patient received tranexamic acid in femoral shaft fracture who operated with plate and screw fixation, randomized control trial.

Status
Recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20220701003
Enrollment
102
Registered
2022-07-01
Start date
2020-11-13
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perioperative bleeding in femoral shaft fracture patient, operated with plate and screw fixation. tranexamic acid, femoral shaft fracture, femur fracture, ORIF, plate and screw, blood transfusion

Interventions

Tranexamic acid injection, 15 mg/kg , intravenous drip in 15-20 minutes, before incision. ,normal saline solution 50 ml , intravenous drip in 15-20 minutes, before incision.
Experimental Drug,Placebo Comparator Drug
tranexamic acid,normal saline solution

Sponsors

Khon Kaen Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1.Age > 18 years old 2.Unilateral Femoral shaft fracture (AO classification type A,B) 3.Operated with ORIF with plate and screw

Exclusion criteria

Exclusion criteria: 1.Associated with hemothorax, intra-abdominal bleeding or pelvic fracture 2.Receive more than one operation during admission 3.Contraindicated in tranexamic acid: TXA allergy, acquired defective color vision ,subarachnoid hemorrhage, history of venous or arterial occlusion disease 4.Pregnancy 5.Underlying disease with dependent transfusion 6.Currently using antifibrinolytic or anticoagulant medications

Design outcomes

Primary

MeasureTime frame
unit of packed red cell transfusion until discharge unit

Secondary

MeasureTime frame
Hemoglobin level post op 24 h until discharge g/dL,adverse event of tranexamic acid (Deep vein thrombosis, Pulmonary Embolism, allergy) until discharge event

Countries

Thailand

Contacts

Public ContactRungprae Jiraratmetacon

Khon Kaen Hospital

superrungp@hotmail.com0819069868

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026